Thomas K. Karikari - Researcher Profile

Publications

3 shown

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari , Tharick A. Pascoal , Nicholas J. Ashton +20 more

2020 The Lancet Neurology 1244 citations

Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials

Pâmela C.L. Ferreira , Bruna Bellaver , Guilherme Povala +26 more

Our findings support that changes in plasma p-tau217 represent a robust endpoint for clinical trials targeting CU or CI individuals with Aβ pathology.

2025 Neurology 0 citations

Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease

Prita R. Asih , Cameron W. Morris , Hong Wang +15 more

Background CSF and blood soluble TREM2 (sTREM2) levels have been found to increase at early stage of Alzheimer's disease (AD). The relationships between sTREM2, AD-related bioma...

2025 Journal of Alzheimer s Disease 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 3
Citations: 1,244
Institution: University of Gothenburg

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1422-4358

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.